TLR3 Activation of Intratumoral CD103(+) Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity

An important challenge in cancer immunotherapy is to expand the number of patients that benefit from immune checkpoint inhibitors (CI), a fact that has been related to the pre-existence of an efficient anti-tumor immune response. Different strategies are being proposed to promote tumor immunity and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Roselli, Emiliano, Araya, Paula, Núñez, Nicolás Gonzalo, Gatti, Gerardo, Graziano, Francesca, Sedlik, Christine, Benaroch, Philippe, Piaggio, Eliane, Maccioni, Mariana
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435583/
https://ncbi.nlm.nih.gov/pubmed/30949170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados